These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 9010327

  • 1. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME, Katzenellenbogen BS.
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG.
    Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
    [Abstract] [Full Text] [Related]

  • 3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE, Madsen MW, Briand P.
    Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R.
    Cancer Res; 1997 Aug 15; 57(16):3486-93. PubMed ID: 9270017
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
    Weaver CA, Springer PA, Katzenellenbogen BS.
    Mol Endocrinol; 1988 Oct 15; 2(10):936-45. PubMed ID: 2460749
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME, Katzenellenbogen BS.
    Cancer Res; 1994 Nov 15; 54(22):5867-74. PubMed ID: 7954416
    [Abstract] [Full Text] [Related]

  • 13. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V, Jensen EV, Knabbe C.
    Cancer Res; 1998 Jan 15; 58(2):263-7. PubMed ID: 9443403
    [Abstract] [Full Text] [Related]

  • 14. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF.
    Cancer Res; 1984 Jan 15; 44(1):112-9. PubMed ID: 6537799
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.
    Hua W, Christianson T, Rougeot C, Rochefort H, Clinton GM.
    J Steroid Biochem Mol Biol; 1995 Dec 15; 55(3-4):279-89. PubMed ID: 8541224
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS, Pink JJ, Jordan VC.
    Cancer Res; 1990 Nov 15; 50(22):7285-92. PubMed ID: 2224859
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
    Borras M, Jin L, Bouhoute A, Legros N, Leclercq G.
    Biochem Pharmacol; 1994 Nov 29; 48(11):2015-24. PubMed ID: 7802690
    [Abstract] [Full Text] [Related]

  • 20. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
    Sommer A, Hoffmann J, Lichtner RB, Schneider MR, Parczyk K.
    J Steroid Biochem Mol Biol; 2003 May 29; 85(1):33-47. PubMed ID: 12798355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.